Patient and physician reactions to generic antiepileptic substitution in the treatment of epilepsy

Epilepsy and Behavior

Volumn 7, Issue 1, 2005, Pages 98-105

  Haskins, Lisa S ^a   Tomaszewski, Kenneth J ^a,b   Crawford, Pamela ^c  

^a Harris Interactive   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^c YORK HOSPITAL   (United Kingdom)

Author keywords

Antiepileptic; Epilepsy; Generic; Multicountry; Neurologists; Patients; Substitution; Survey

Indexed keywords

ANTICONVULSIVE AGENT; GENERIC DRUG;

ADOLESCENT; ADULT; ARTICLE; CANADA; COST BENEFIT ANALYSIS; DOCTOR PATIENT RELATION; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; EPILEPSY; FEMALE; FRANCE; GERMANY; HEALTH SURVEY; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PREVALENCE; RISK ASSESSMENT; SEIZURE; SPAIN; TELEPHONE; UNITED KINGDOM; WELFARE;

ADULT; ANTICONVULSANTS; CROSS-SECTIONAL STUDIES; DRUGS, GENERIC; EPILEPSY; FEMALE; HEALTH CARE SURVEYS; HUMANS; MALE; PHYSICIAN'S ROLE; PHYSICIANS; THERAPEUTIC EQUIVALENCY;

EID: 22144474791     PISSN: 15255050     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yebeh.2005.04.005     Document Type: Article

References (13)

1. A. Guberman C. Corman Generic substitution for brand name antiepileptic drugs: A survey Can J Neurol Sci 27 2000 37-43
2. Comment in Neurology [editorial]. Neurology 1991;41:1165.
3. J.T. Gilman L.A. Alvarez M. Duchowny Carbamazepine toxicity resulting from generic substitution Neurology 42 1993 2696-2697
4. T.E. Welty P.R. Pickering B.C. Hale R. Arazi Loss of seizure control associated with generic substitution of carbamazepine Ann Pharmacother 26 1992 775-777
5. A.J. Finestone F.F. Williams Generic substitution resulting in toxicity Pennsylvania Med 88 1985 34
6. A.N. Wilner Physicians underestimate the frequency of generic carbamazepine substitution: Results of a survey and review of the problem Epilepsy Behav 3 2002 522-525
7. D.H. Rosenbaum A.J. Rowan L. Tuchman J.A. French Comparative bioavailability of a generic phenytoin and Dilantin Epilepsia 35 1994 656-660
8. Policy relating to generic medicines in the OECD [online]. 1995 [cited 2004 Nov 30]. Available from: URL: http://pharmacos.eudra.org/F2/pharmacos/docs/nerareport.pdf.
9. CIA-The World Fact Book [online]. 2004 [cited 2004 Nov 30]. Available from: URL: http://www.cia.gov/cia/publications/factbook/geos/gm.html.
10. M.C. Meyer A.B. Straughn R.M. Mhatre V.P. Shah R.L. Williams L.J. Lesko The relative bioavailability and in vivo-in vitro correlations for four marketed carbamazepine tablets Pharm Res 15 1998 1787-1791
11. A. Yacobi S. Zlotnick J.L. Colaizzi et al. A multiple-dose safety and bioequivalence study of a narrow therapeutic index drug: A case for carbamazepine Clin Pharmacol Ther 65 1999 389-394
12. A.N. Wilner Therapeutic equivalency of generic antiepileptic drugs: results of a survey Epilepsy Behav 5 2005 995-998
13. J.T. MacDonald Breakthrough seizure following substitution of Depakene capsules (Abbott) with a generic product Neurology 37 1987 1885